60 Degrees Pharmaceuticals, Inc. (SXTP): Free Cash Flow
-$6.99M
Year ended 2025-12-31
-$8.89M
Trailing 12 months to 2026-06-30
| Period ended | Free Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$6.99M | n/m | 2026-03-30, From 2025-01-01 |
| 2024-12-31 | -$5.75M | n/m | 2026-03-30, From 2024-01-01 |
| 2023-12-31 | -$4.60M | n/a | 2025-03-27, From 2023-01-01 |
Free Cash Flow at similar companies
| Company | Year ended | Free Cash Flow | Change YoY |
|---|---|---|---|
| 60 Degrees Pharmaceuticals, Inc. (SXTP) | 2025-12-31 | -$6.99M | n/m |
| Shattuck Labs, Inc. (STTK) | 2025-12-31 | -$39.95M | n/m |
| Dare Bioscience, Inc. (DARE) | 2025-12-31 | -$10.29M | n/m |
| Rafael Holdings, Inc. (RFL) | 2025-07-31 | -$18.93M | n/m |
| Bespoke Extracts, Inc. (BSPK) | 2024-12-31 | -$889.8K | n/a |
| China SXT Pharmaceuticals, Inc. (SXTC) | 2025-03-31 | -$2.35M | n/m |
| Rallybio Corp (RLYB) | 2024-12-31 | -$49.28M | n/m |
| Longeveron Inc. (LGVN) | 2025-12-31 | -$18.89M | n/m |
| Onconetix, Inc. (ONCO) | 2024-12-31 | -$10.52M | n/m |
Compare SXTP, STTK, DARE, RFL side by side · Screen every company in Pharmaceutical Preparations ↗